| Checkpoint-inhibition in ovarian cancer: rising star or just a dream? K Pietzner, S Nasser, S Alavi, S Darb-Esfahani, M Passler, MZ Muallem, ... Journal of gynecologic oncology 29 (6), 2018 | 43 | 2018 |
| Implementation of enhanced recovery after surgery (ERAS) pathways in gynecologic oncology. A NOGGO-AGO* survey of 144 gynecological departments in Germany MZ Muallem, D Dimitrova, K Pietzner, R Richter, A Feldheiser, I Scharfe, ... Anticancer Research 36 (8), 4227-4232, 2016 | 40 | 2016 |
| HE4 expression in plasma correlates with surgical outcome and overall survival in patients with first ovarian cancer relapse EI Braicu, R Chekerov, R Richter, C Pop, M Nassir, H Loefgren, ... Annals of surgical oncology 21, 955-962, 2014 | 36 | 2014 |
| ERCC1 expression as a predictor of resistance to platinum-based chemotherapy in primary ovarian cancer MZ Muallem, I Braicu, M Nassir, R Richter, J Sehouli, R Arsenic Anticancer research 34 (1), 393-399, 2014 | 36 | 2014 |
| Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer C Fotopoulou, A El-Balat, A du Bois, J Sehouli, P Harter, MZ Muallem, ... Archives of gynecology and obstetrics 292, 1321-1327, 2015 | 33 | 2015 |
| Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection (L-TMMR): a multicentric experience V Chiantera, G Vizzielli, A Lucidi, V Gallotta, M Petrillo, F Legge, A Fagotti, ... Gynecologic Oncology 139 (1), 47-51, 2015 | 31 | 2015 |
| Endometrial Cancer Lymphadenectomy Trial (ECLAT)(pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP. 6) G Emons, JW Kim, K Weide, N De Gregorio, P Wimberger, F Trillsch, ... International Journal of Gynecologic Cancer 31 (7), 2021 | 26 | 2021 |
| AGO score as a predictor of surgical outcome at secondary cytoreduction in patients with ovarian cancer MZ Muallem, K Gasimli, R Richter, J Almuheimid, S Nasser, EI Braicu, ... Anticancer Research 35 (6), 3423-3429, 2015 | 26 | 2015 |
| Nerve sparing radical hysterectomy: short-term oncologic, surgical, and functional outcomes MZ Muallem, R Armbrust, J Neymeyer, A Miranda, J Muallem Cancers 12 (2), 483, 2020 | 25 | 2020 |
| Preoperative evaluation of myometrial invasion in endometrial carcinoma: prospective intra-individual comparison of magnetic resonance volumetry, diffusion-weighted and dynamic … SF Thieme, F Collettini, J Sehouli, L Biocca, A Lella, M Wagner, ... Anticancer research 38 (8), 4813-4817, 2018 | 25 | 2018 |
| Lymph node involvement pattern and survival differences of FIGO IIIC and FIGO IIIA1 ovarian cancer patients after primary complete tumor debulking surgery: a 10-year … K Gasimli, EI Braicu, M Nassir, R Richter, A Babayeva, R Chekerov, ... Annals of surgical oncology 23, 1279-1286, 2016 | 25 | 2016 |
| Nerve-sparing radical hysterectomy: steps to standardize surgical technique MZ Muallem, Y Diab, J Sehouli, S Fujii International Journal of Gynecologic Cancer 29 (7), 2019 | 23 | 2019 |
| The impact of surgical staging on the prognosis of mucinous borderline tumors of the ovaries: a multicenter study K Gungorduk, O Asicioglu, EI Braicu, J Almuheimid, SG Gokulu, ... Anticancer research 37 (10), 5609-5616, 2017 | 23 | 2017 |
| Maternal serum VEGF predicts abnormally invasive placenta better than NT-proBNP: a multicenter case-control study A Schwickert, F Chantraine, L Ehrlich, W Henrich, MZ Muallem, ... Reproductive Sciences 28, 361-370, 2021 | 22 | 2021 |
| Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer MZ Muallem, J Sehouli, R Richter, A Babayeva, K Gasimli, ... International Journal of Gynecologic Cancer 30 (1), 2020 | 22 | 2020 |
| Targeted therapy in ovarian cancer. A comprehensive systematic review of literature Y Diab, MZ Muallem Anticancer Research 37 (6), 2809-2815, 2017 | 21 | 2017 |
| Risk factors of lymph nodes metastases by endometrial cancer: a retrospective one-center study MZ Muallem, J Sehouli, J Almuheimid, R Richter, R Joukhadar, H Plett Anticancer Research 36 (8), 4219-4225, 2016 | 21 | 2016 |
| ERCC1 expression as a predictive marker of cervical cancer treated with cisplatin-based chemoradiation MZ Muallem, S Marnitz, R Richter, C Koehler, J Sehouli, R Arsenic Anticancer Research 34 (1), 401-406, 2014 | 21 | 2014 |
| A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer GF Vercellino, E Erdemoglu, P Lichtenberg, MZ Muallem, R Richter, ... Archives of gynecology and obstetrics 300, 191-199, 2019 | 20 | 2019 |
| Diaphragmatic surgery in advanced ovarian, tubal and peritoneal cancer. A 7-year retrospective analysis of the tumor bank ovarian cancer network MZ Muallem, J Almuheimid, R Richter, EI Braicu, S Osman, J Sehouli Anticancer Research 36 (9), 4707-4713, 2016 | 20 | 2016 |
